Find more information on the issues deeply affected by private equity investments:
The future of Walgreens, an iconic Chicago drugstore, looks grim The pharmacy and retail store now counts itself as one of thousands of portfolio companies owned by private equity, an industry renowned for its profits-first, people-last approach to business.
In light of continued investor interest in healthcare and the risks associated with private equity ownership of healthcare companies, the Private Equity Stakeholder Project is tracking private equity-backed healthcare acquisitions. Below is a list of private equity healthcare buyouts,…
The Private Equity Stakeholder Project (PESP) was founded in 2017 to address the growing impacts of private equity on people and the planet. We are a resource to the communities, individuals, and organizations grappling with these impacts. In the coming…
Why Walgreens’ New CEO Should Alarm Us The man who oversaw massive store closures and job cuts at Staples is now in charge of one of America’s most important companies. The following op-ed…
Genesis Healthcare bankruptcy shows why joint liability is needed to hold private equity accountable Private equity increasingly uses bankruptcy courts to walk away from harm—not just Genesis The Genesis Healthcare bankruptcy has again prompted the Private Equity Stakeholder Project (PESP)…
As states across the country confront the growing risks of private equity ownership in hospitals, nursing homes, and physician practices, PESP’s 2025 State Healthcare Policy Review: Tracking Private Equity Oversight and Reform and…
Each month, PESP’s Healthcare Team will be putting together a roundup that shares the latest news stories related to private equity in healthcare and highlights the work that our team has published in the last month. In the…
In light of continued investor interest in healthcare and the risks associated with private equity ownership of healthcare companies, the Private Equity Stakeholder Project is tracking private equity-backed healthcare acquisitions. Below is a list of private equity healthcare buyouts,…
Private equity’s expansion into the clinical trial industry is accelerating and may reshape how medical studies are conducted and overseen. The growing consolidation of research sites and ethics review boards raises concerns about trial safety, the long-term…
In 2025, state legislatures across the country advanced a wave of proposals to rein in the risks of private equity in healthcare. Spurred by hospital closures, bankruptcies, and mounting evidence of financial extraction by private investors, lawmakers in…
States move to rein in private equity’s growing control of healthcare, new report finds Private Equity Stakeholder Project report tracks 2025 legislative wave targeting financial risks and ownership opacity in healthcare State lawmakers across the country advanced an unprecedented wave…
PESP Shares Concerns About Private Equity’s Role in Rising Healthcare Costs at Washington’s Health Care Cost Transparency Board On October 23, the Washington Health Care Cost Transparency Board (HCCTB) convened to examine the financial and structural pressures…
